republic-os/legal/us/code/title-50/chapter-45/section-3329.md

type, title, description, jurisdiction, corpus, kind, title_number, title_name, chapter_number, chapter_name, section, citation, status, release_point, release_date, source, source_url, source_identifier, source_file, source_hash, raw_snapshot_hash, text_hash, retrieved_at, confidence, tags

type	title	description	jurisdiction	corpus	kind	title_number	title_name	chapter_number	chapter_name	section	citation	status	release_point	release_date	source	source_url	source_identifier	source_file	source_hash	raw_snapshot_hash	text_hash	retrieved_at	confidence	tags
LegalText	50 U.S.C. § 3329	Intelligence community contracting	us	united_states_code	code_section	50	WAR AND NATIONAL DEFENSE	45	MISCELLANEOUS INTELLIGENCE COMMUNITY AUTHORITIES	3329	50 U.S.C. § 3329	current	119-100	2026-06-26	official	https://uscode.house.gov/download/releasepoints/us/pl/119/100/xml_usc50@119-100.zip	/us/usc/t50/s3329	data/legal/raw/us/code/title-50/usc50.xml	df8d0b87eaa9558efea2c684b7af5afc1171f34986e9730d5fff970687d3458e	708c288b5448617cab7b03b8011860274671c9aec56686858b910a06948cd7ac	996bb6539940fd52f14825b197f953648926754e03b6fdf7c4d1f188052d4035	2026-07-04	official	legal us-code

50 U.S.C. § 3329 - Intelligence community contracting

Text

(a) In general The Director of National Intelligence shall direct that elements of the intelligence community, whenever compatible with the national security interests of the United States and consistent with the operational and security concerns related to the conduct of intelligence activities, and where fiscally sound, shall award contracts in a manner that would maximize the procurement of products in the United States.

(b) Intelligence community defined In this section, the term “intelligence community” has the meaning given that term in section 3003(4) of this title.

(Pub. L. 102–183, title IV, § 403, Dec. 4, 1991, 105 Stat. 1267; Pub. L. 111–259, title VIII, § 810, Oct. 7, 2010, 124 Stat. 2750.)

Notes

Editorial Notes

Codification Section was formerly classified to section 403–2 of this title prior to editorial reclassification and renumbering as this section.

Prior ProvisionsProvisions similar to those in this section were contained in the following prior authorization act: Pub. L. 102–88, title IV, § 404, Aug. 14, 1991, 105 Stat. 434.

Amendments2010—Pub. L. 111–259 added subsec. (b), designated existing provisions as subsec. (a), inserted heading, substituted “Director of National Intelligence” for “Director of Central Intelligence” and “intelligence community” for “Intelligence Community”, and struck out at end “For purposes of this provision, the term ‘Intelligence Community’ has the same meaning as set forth in paragraph 3.4(f) of Executive Order 12333, dated December 4, 1981, or successor orders.”

Statutory Notes and Related Subsidiaries

Prohibition on Intelligence Community Contracting With Chinese Military Companies Engaged in Biotechnology Research, Development, or ManufacturingPub. L. 119–60, div. F, title LXVII, § 6703, Dec. 18, 2025, 139 Stat. 1644, provided that: “(a) Definitions.—In this section:“(1) 1260H list.—The term ‘1260H list’ means the list of Chinese military companies operating in the United States most recently submitted under section 1260H(b)(1) of the William M. (Mac) Thornberry National Defense Authorization Act for Fiscal Year 2021 [Pub. L. 116–283] (10 U.S.C. 113 note). “(2) Affiliate.—The term ‘affiliate’ means an entity that directly or indirectly controls, is controlled by, or is under common control with another entity. “(3) Biotechnology.—The term ‘biotechnology’ means the use of biological processes, organisms, or systems for manufacturing, research, or medical purposes, including genetic engineering, synthetic biology, and bioinformatics. “(b) Prohibition.—Subject to subsections (d) and (e), a head of an element of the intelligence community may not enter into, renew, or extend any contract for a product or service with—“(1) any entity listed on the 1260H list that is engaged in biotechnology research, development, or manufacturing activities; “(2) any entity that is a known or assessed affiliate of any entity described in paragraph (1); “(3) any entity that has a known or assessed joint venture, partnership, or contractual relationship with any entity described in paragraph (1), if the Director of National Intelligence determines that the relationship presents a risk to the national security of the United States; or “(4) any other entity that is engaged in biotechnology research, development, or manufacturing activities, if the Director of National Intelligence determines that the activities present a risk to the national security of the United States. “(c) Implementation and Compliance.—The Director of National Intelligence shall, in consultation with the heads of the elements of the intelligence community—“(1) establish guidelines for the implementation of this section; “(2) maintain both a publicly available and classified list of entities covered by the prohibition in subsection (b); “(3) require that each head of an element of the intelligence community ensure that any contractor engaged by the element certify that neither it nor any of its subcontractors are engaged in a contract for a product or service with an entity covered by the prohibition in subsection (b); and “(4) otherwise ensure compliance with subsection (b). “(d) Waiver Process.—“(1) In general.—The Director of National Intelligence may establish a waiver process for the heads of the elements of the intelligence community under which the head of the relevant element may waive the prohibition under subsection (b) for a procurement on a case-by-case basis. A waiver may be made under the process only if the head of the relevant element—“(A) complies with any conditions the Director may establish for the process; and “(B) determines, in writing, that—“(i) the procurement is essential for national security and no reasonable alternative source exists; and “(ii) appropriate measures are in place to mitigate risks associated with the procurement. “(2) Congressional notification.—For each waiver for a procurement issued under subsection (b) [probably should be “paragraph (1)”], the Director and the relevant head of the element of the intelligence community shall, not later than 30 days after issuing the waiver, submit to the congressional intelligence committees, the Committee on Appropriations of the Senate, and the Committee on Appropriations of the House of Representatives a notice of the waiver, which shall include a justification for the waiver and a description of the risk mitigation measures implemented for the procurement. “(e) Exceptions.—The prohibition in subsection (b) shall not apply to—“(1) the acquisition or provision of health care services overseas for—“(A) employees of the United States, including members of the uniformed services (as defined in section 101(a) of title 10, United States Code), whose official duty stations are located overseas or who are on permissive temporary duty travel overseas; or “(B) employees of contractors or subcontractors of the United States—“(i) who are performing under a contract that directly supports the missions or activities of individuals described in subparagraph (A); and “(ii) whose primary duty stations are located overseas or who are on permissive temporary duty travel overseas; or “(2) the acquisition, use, or distribution of human multiomic data, lawfully compiled, that is commercially or publicly available. “(f) Effective Date.—This section shall take effect on the date that is 60 days after the date of the enactment of this Act [Dec. 18, 2025] and apply to any contract entered into, renewed, or extended on or after such effective date. “(g) Sunset.—The provisions of this section shall terminate on the date that is 10 years after the date of the enactment of this Act. “(h) Rule of Construction.—This section shall only be construed to apply to activities of an element of the intelligence community.” [For definitions of “intelligence community” and “congressional intelligence committees” as used in section 6703 of Pub. L. 119–60, set out above, see section 6002 of Pub. L. 119–60, set out as a note under section 3003 of this title.]

Enhanced Procurement Authority To Manage Supply Chain RiskPub. L. 112–87, title III, § 309, Jan. 3, 2012, 125 Stat. 1883, formerly set out as a note under this section, was transferred to section 3334e of this title.